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Abstract of thesis entitled: 
Characterization of a Mouse Model of Shrimp Allergy 
Submitted by LEE Yuen-Shan 
for the degree of Master of Philosophy 
at the Chinese University of Hong Kong in September 2007 
Shrimp allergy is a common form of food allergies. Tropomyosin was found 
to be the major shellfish allergen. Despite years of studies, pathological 
mechanism of food allergy is still obscure. No effective treatments are available 
for curing the disease. As it is unethical to do sensitization studies in human 
subjects, a number of animal models have been developed for studying allergic 
disease. In our laboratory, a murine model of shrimp allergy has been developed. 
The objective of this study is to further characterize the humoral and cellular 
responses in allergic mice. 
Shrimp (Metapenaeus ensis) tropomyosin was cloned in His-tag expression 
vector pQE-30 in the previous study in our laboratory. The vector was 
transformed into E. coli for expression of recombinant shrimp tropomyosin. The 
expressed protein was then purified by nickel-nitrilotriacetic acid agarose beads 
and dialysed in phosphate buffered saline overnight. 
Three to four-week-old female BALB/c mice were sensitized with 0.1 mg 
recombinant shrimp tropomyosin and cholera toxin as the adjuvant on days 0’ 12, 
19 and 26. They were challenged with 1 mg tropomyosin and toxin on day 33. 
Mice fed with saline or histidine peptide were studied in parallel. 
—二 ^ - • • … . — - - - • - - •- • - • 
i 
Mice fed with recombinant shrimp tropomyosin developed signs of allergic 
responses. These mice exhibited systemic hypersensitive responses, including 
scratching around nose and head, swelling of snout and laboured respiration. 
Induction of shrimp tropomyosin-specific IgE was also observed in these mice. 
Only sera from sensitized mice could elicit passive cutaneous anaphylaxis 
reaction in naive mice. In vitro study showed a significant proliferative response 
of CD4+ cell upon the stimulation of shrimp tropomyosin. A mixed cytokine 
response was exhibited by restimulated splenocytes, in which both Thl，Th2 
related cytokines and proinflammatory chemokine were significantly expressed in 
sensitized mice. 
It is concluded that the oral sensitization of mice with shrimp tropomyosin 
elicited hypersensitive reactions that resemble those in allergic patients. This 
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Food allergy is an adverse immune response to food proteins (Sicherer 
& Sampson，2006). Recent epidemiological surveys reveal that 4% of the 
general population are estimated to have IgE-mediated food allergies (Kanny 
et al , 2001; Munoz-Furlong, 2004). Food allergic reactions account for one 
third to one-half of anaphylaxis cases in emergency departments in North 
America, Europe, Asia and Australia (Brown et al., 2001; Sampson, 2003; 
Smit et al., 2005). All these figures indicate the prevalence and severity of 
food allergies worldwide. 
Among various food items, seafood is well known to be a causative 
food in eliciting allergic responses in human. As shrimp allergy is one of the 
common forms of seafood allergies, it is essential to advance our 
understanding on this disease. After years of study on seafood allergy, the 
major finding is the identification of muscle protein, tropomyosin, as the 
major shellfish allergen (Chu et al., 2005). 
Animal models have long been used as a tool in studying the 
mechanisms of human diseases due to the high similarity of immune systems 
between animal and human subjects. In order to facilitate investigations on 
shrimp allergy, a murine model of shrimp allergy has been developed in our 
laboratory. BALB/c mice that were sensitized with recombinant shrimp 
tropomyosin elicited various allergic symptoms (Tang, 2004). The major 
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focus of the present study is to further characterize the reactions in allergic 
mice, especially on the T cell responses. 
Chapter 2 of this thesis is a literature review on background information 
of food allergy, immunopathological mechanisms of food allergy, studies on 
seafood allergy, and studies of animal models on food allergy. Chapter 3 
describes the preparation of recombinant shrimp tropomyosin and presents 
the studies on hypersensitive responses in the murine model. A general 






This chapter reviews the literature on the following topics: (1) history of 
food allergy research; (2) prevalence of food allergy; (3) clinical symptoms 
of food allergy; (4) mechanisms of food allergy; (5) studies on seafood 
allergy; and (6) use of animal models in the study of food allergy. 
2.1 History of food allergy research 
Food allergy is defined as abnormal immunological responses due to 
oral exposure to food allergens (Mansueto et al.，2006; Sicherer & Sampson, 
2006). The study of food adverse reactions began in the early century 
after several clinical reports of anaphylaxis in patients after ingestion of 
common food substances (Untersmayr & Jensen-Jarolim，2006). The most 
groundbreaking study on food allergy research was done by PraUvsnitz and 
Ktiestner (1921). In their study, an immediate skin response was evoked on 
PraUvsnitz's forearm at sites where Kiiestner's serum had been injected. 
They were the first group in demonstrating transferable humoral factor was 
responsible for food allergy. This initiated the search of reagenic agent in 
causing these adverse reactions. After several decades of study, a new class 
of immunoglobulin was identified as the mediator of allergic response 
(Ishizaka & Ishizaka，1967; Wide et al., 1967) and was termed as IgE (Juhlin 
et al” 1969). This represents the milestone of allergy research. Since then, 
more investigations were carried out based on clinical and animal studies. 
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These advance our knowledge on the underlying mechanisms of food 
allergic diseases and the development of potential therapeutic strategies for 
this disorder, which will be discussed in more detail in the latter sections. 
2.2 Prevalence of food allergy 
Prevalence of food allergy has been documented in many western 
countries. A recent survey indicated that there is an increased occurrence of 
� 
food allergy in the United States, Europe and Australia, and food allergy is 
recognized as the most common cause of anaphylaxis in many countries 
(Sampson, 2004). In the United States, about 6% of infants and young 
children and 3 to 4% of adults have food allergy (Sicherer & Sampson, 2006). 
In paediatric population, the most common causal foods are cow's milk, egg, 
peanut, wheat, soy, tree nuts, fish and shellfish. In adults, the most common 
causal foods are shellfish, peanut, tree nuts and fish (Sampson, 2004). It is 
found that most paediatric patients outgrow their allergies to cow's milk and 
egg allergies, while allergies to shellfish, peanut and tree nut are considered 
generally permanent once the allergic responses are established (Wang & 
Sampson, 2007). There may be a more urgent need of developing effective 
treatment for these life-long allergies. 
In the past, not much information on prevalence of food allergies in 
Asia was published. Nowadays, more Asian countries are aware of this 
life-threatening disease. It is worried that there will be a rise in food allergy 
following the rise in asthma, as experienced in many other urbanized 
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countries (Walker-Smith, 2005). Based on some recent epidemiological 
studies on allergic patients admitted into hospitals, the profile of food 
allergens in Asian regions was identified. They illustrated that young 
Japanese and Korean children usually suffer from egg, milk and seafood 
allergies (likura et al.，1999; Oh et al.，2004). It seems that milk and egg 
allergies are universal to all countries (Hill & Hosking，1997). However, the 
profile of other food allergens appears to vary greatly between Asian and 
Western regions. The major difference is that seafood, rather than peanuts 
and tree nuts, was found to be the most common causative food in Asian 
regions, such as Singapore (Thong et al., 2007) and Hong Kong (Smit et al., 
2005). Another interesting point is that some food allergens are unique and 
first described in Asian population. Two examples are the bird's nest and 
buckwheat (Shek & Lee.，2006). Bird's nest is a Chinese cuisine made from 
the saliva of the swiftlet, which is used to build their nests and is the most 
common cause of food-induced anaphylaxis among Singapore children (Goh 
et al., 1999). It is documented that the major allergen in 'bird's nest，is a 66 
kD glycoprotein that could be recognized by IgE antibodies from those 
allergic children (Goh et al., 2001). Another example is buckwheat allergy. 
Cases have been reported in China, Japan and Korea (Lee et al” 2001; 
Wieslander et al., 2000). Buckwheat is widely used in making noodles, cakes 
and biscuits, especially in Japan. It was ranked fourth in causing 
immediate-type food allergy in Japan (Imai et al., 2003). These examples 
illustrate different dietary factors may influence the prevalence of different 
food allergies (Wang & Sampson，2007). 
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2.3 Clinical symptoms of food allergies 
Food allergic disorders are classified based on the involvement of 
humoral or/and cellular immune systems that will result in different clinical 
symptoms (Sampson, 2004). The reaction will typically start within minutes 
to an hour after ingestion of food allergens and may affect multiple target 
organs, including skin, respiratory tract and gastrointestinal tract (Sampson, 
2004). In some extremely sensitive patients, minute amount of allergens is 
enough in triggering the reactions (Sampson, 2004). In general, angioedema, 
flushing, cough, wheezing, congestion, vomiting, diarrhea and cramping 
abdominal pain are the commonly observed reactions in allergic patients 
(Sampson, 2004). The most fatal reaction is known as anaphylaxis. It leads to 
the hypotension, vascular collapse and cardiac dysrhythmias and even death 
in some patients (Pumphrey, 2000). Therefore, it is important to develop 
precise diagnosis in identifying responsible food allergen. In the mean time, 
strict avoidance of causative foods is necessary in minimizing the adverse 
effects of these reactions on patients. 
2.4 Mechanisms of food allergy 
Since the discovery of IgE antibody 40 years ago, numerous studies on 
animal models and allergic patients were carried out. Although detailed 
immunological mechanism of food allergy remains unclear, a general 
consensus has been established in the field. 
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The gastrointestinal tract is the largest immune organ of the human 
body and represents the vastest site of exposure with pathogens and 
exogenous soluble antigens (MacDonald & Monteleone, 2005). Since birth, 
the gastrointestinal tract is exposed to different kinds of antigens, including 
both harmful (e.g. pathogens) and non-harmful (e.g. commensal bacteria and 
digested food substances). In majority, a well balanced homeostasis between 
the defence of harmful substances and the induction of tolerance towards 
nutritional substances is established in human. However, in allergic patients, 
they become immunologically sensitized and lack the tolerance to those food 
protein or peptides. It is believed that the food allergens can get into the 
immune system through several routes and the route in presenting the 
allergens to T and B cells seems to be a critical step in deciding whether oral 
tolerance or sensitization is the consequence (Chase, 1946). In addition, it is 
now characterized that some dietary proteins have distinct features that 
increase their allergenicity. 
2.4.1 Properties of food allergens 
Most food allergens are water-soluble glycoproteins of size ranged from 
10 to 70 kD that are stable to heat, acid and proteases, such as proteins in 
milk, peanut and egg (Sicherer & Sampson, 2006). Due to the increased 
resistance to food processing and gastric digestion, the concentration of 
intact dietary proteins in the gastrointestinal tract is elevated. On the other 
hand, a food item may be comprised of numerous allergens with different 
levels of allergenicity. For example, peanut contains three major allergens 
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(Ara h 1，Ara h 2 and Ara h 3) that are associated with severe clinical 
reactions, while exposure to another peanut allergen, Ara h 8, induces milder 
reactions in most patients (Sicherer & Sampson, 2006). In addition, 
cross-reactivity between dietary proteins has been clinically reported, such as 
between peanut and tree nut allergens (de Leon et al., 2007), and between 
shrimp, crab and scallop (Zhang et al., 2006). Cross-reactive properties of 
allergens increase the difficulties in identifying the causative food substances 
in atopic patients. 
2.4.2 Exposure to food allergens in the gastrointestinal tract 
The first exposure of food proteins in our body is the oral cavity. The 
oral mucosa is part of mucosal associated lymphoid tissues (MALT) and thus 
it allows the contact of the food allergen with immune competent cells 
(Walker, 2004). Evidence showed that intact peanut proteins can be 
effectively absorbed via the oral mucosa (Dirks et al., 2005). This may 
explain the induction of immediate allergic reactions a few minutes after oral 
exposure. 
After ingestion, most of the food proteins are subjected to digestion by 
pepsin and acid into peptides and free amino acids. Oligopeptides that are 
comprised of eight or less amino acid residues are generally 
immunologically ignored (York et al., 1999). As mentioned, some food 
proteins may escape or resist protein digestion. They are then absorbed in an 
intact form and prime an immune response (Untersmayr & Jensen-Jarolim， 
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2006). Another factor that increases the exposure of the intact allergen is 
developmental immaturity of the components of gut barrier in newborns 
(Sampson, 2004). Secretory IgA system is immature in infants until four 
years old (Mayer, 2003). This results in a reduced efficacy of gut barrier in 
preventing the penetration of pathogens and large particles. Increased 
intestinal permeability facilitates the uptake of intact food proteins in the 
circulation that leads to the stimulation of immune system and induction of 
allergic reactions (Sampson, 1999). Gradual maturation of the gut barrier 
corresponds to decreased prevalence of food allergy in the first two years of 
life, and may explain why allergic children can outgrow their allergies to 
food as they grow up (Sampson, 1999). Another factor contributed to the 
prevalence of food allergy in young children is the inactive digestive 
enzymatic activity (Mayer, 2003). Some food proteins cannot be digested 
and thus retain their allergenicity. In fact, inadequate protein digestion is not 
only the cause of allergy induction in infants and children, but also in adult 
patients who suffer from gastric ulcer and have received medications to 
lower gastric pH (Untersmayr et al.，2005). This further supports the 
hypothesis that retaining food protein allergenicity together with reduced gut 
barrier leads to sensitization in both paediatric and adult patients. 
2.4.3 Oral tolerance and its relationship to food allergy 
Despite the maturity state of mucosal barrier in healthy adults, about 2% 
of the ingested food antigens are absorbed and transported throughout the 
body in an immunologically intact form (Husby et al., 1987; Husby, 2000)， 
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which may either induce reactions in allergic patients or result in a state of 
unresponsiveness in normal individuals. The unresponsive state is known as 
oral tolerance. It is hypothesized that oral tolerance is the result of T cell 
anergy or induction of regulatory T cells (Sampson, 2004). Dependent on the 
dosage of antigen, different forms of oral tolerance are mediated. High-dose 
tolerance is resulted from T cell anergy or deletion, while low-dose form is 
mediated by regulatory T cells (Chehade & Mayer，2005). 
In high-dose tolerance, T cell anergy is induced when T cell receptor 
ligation occurs in the absence of costimulatory signals provided either by 
soluble cytokines (IL-2) or by interaction between costimulatory receptors 
(CD28) and counter-receptors on antigen-presenting cells (APCs) (CD80 and 
CD86) (Appleman & Boussiotis, 2003; Chehade & Mayer，2005). On the 
other hand, high-dose of allergen can lead to FAS-mediated apoptosis which 
results in T cell deletion. 
On the other hand，low-dose tolerance is achieved with the help of 
various subgroups of regulatory T cells and APCs. Both suppressor CD8+ 
and regulatory CD4+ cells are responsible for oral tolerance induction to food 
antigens (Barone et al., 1995; Chehade & Mayer, 2005; Chen et al , 1995; 
Garside et al., 1995). Suppressor CD8+ cells function together with intestinal 
epithelial cells can induce low-dose tolerance. These epithelial cells can 
express major histocompatibility complex (MHC) class II molecules (Mason 
et al., 1981; Scott et al., 1980) and are capable of antigen presentation to 
primed T cells. Similar to other non-professional APCs, intestinal epithelial 
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cells normally selectively activate CD8+ suppressor T cells, playing a role in 
local suppression of immune responses (Bland & Warren, 1986; Mayer & 
Shlien, 1987). However, in allergic patients, CD23-bearing intestinal 
epithelial cells deliver IgE-allergen complexes to mucosal mast cells (Berin 
et al., 1997; Yu et al., 2001). This may provide an active shuttle transport for 
IgE across the intestinal epithelium (Tu et al” 2005). 
f 
Regulatory CD4+ cells related to oral induction are divided into three 
subgroups: Th3 cells, TrI cells and CD4+CD25+ cells (Barone et al., 1995; 
Chen et al., 1995; Garside et al., 1995). Th3 cells produce TGF-P that serves 
as a switch factor for IgA production (Kim & Kagnoff，1990). As mentioned, 
secretory IgA is one of components of gut barrier against food allergens. TrI 
cells are IL-10 producing cells. IL-10 was shown to suppress 
antigen-specific immune responses in mice. CD4+CD25+ cells produce 
regulatory cytokines TGF-P and IL-10 in mice (Zhang et al., 2001). They 
also express the transcription factor forkhead box P3 (F0XP3) (Fontenot et 
al , 2003; Khattri et al., 2003). It was shown that production of F0XP3 
ensures blockade of Thl and Th2 induction in a murine model (Ostroukhova 
et al., 2004). In sum, these regulatory lymphocytes play a role in oral 
tolerance induction by actively producing immunomodulating cytokines and 
thus keeping a balance between Thl/Th2 responses. The absence of oral 
tolerance in young allergic patients or loss of established tolerance in adult 
patients would result in food allergy. 
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The factors in determining whether tolerance induction can be 
successfully established remain obscure. It is suggested that genetics of 
individuals and composition of commensal gut flora may determine whether 
oral tolerance or sensitization is the consequence after exposure to food 
antigens. The genetic influence of the induction of food allergy was 
supported by studies on murine models of cow's milk and peanut allergy 
(Morafo et al., 2003). They demonstrated that C3H/HeJ mice strain is more 
susceptible to be sensitized than BALB/c mice strain as C3H/HeJ mice 
exhibited anaphylactic reactions and antigen-specific IgE production on 
sensitization and challenge with cow's milk or peanut. Further experiments 
have shown that the strain-dependent susceptibility to food allergy is due to 
absence of functional toll-like receptor 4 which inhibits the development of 
allergic responses to food antigens in mice (Bashir et al., 2004). Studies in 
comparing loci of specific human leukocyte antigen (HLA) between food 
allergic patients and normal individuals were also done. However, different 
results were observed. Verkasalo et al. (1983) found no differences in the loci 
of HLA antigen between the milk allergic and non-allergic individuals. Yet 
Howell et al. (1998) reported several genotypes were at higher frequencies in 
peanut allergic patients than in control subjects. Although no specific HLA 
loci associated with food allergy were recognized, this study clearly shows 
that the risk of allergy is substantially increased if first-degree relatives are 
afflicted. These findings suggest that genetic background may not be the key 
factor, but at least contributes to the elicitation of allergic reactions (Chehade 
& Mayer，2005). 
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Presence of commensal gut flora might also influence the types of 
mucosal immune response established. Gut flora is established immediately 
after birth and is dependent on maternal flora and local environment 
(Mansueto et al.，2006). Gut flora produces interferon-a (IFN-a) that can 
enhance Thl responses but inhibit the development of Th2 responses (Smith 
& Nagler-Anderson, 2005; Brandtzaeg, 2002). ‘ 
In conclusion, when the oral tolerance to food antigens fails to establish, 
individuals become sensitized to ingested food protein. The ability to induce 
tolerance may depend on the cellular interaction on antigen presentation, 
cytokine microenvironment in the gut contributed by the regulatory 
lymphocytes or commensal bacteria and the genetic predisposition of 
individuals. 
2.4.4 Cellular mechanism of food allergy 
Development of IgE-mediated food allergy involves a series of complex 
molecular and cellular interactions. The interactions are briefly illustrated in 
figure 2.1. As stated, some dietary proteins may resist or escape from gastric 
digestion. In the gut, they are taken up by specialized epithelial cells (also 
known as M cells) (Kraehenbuhl & Neutra，2000), intestinal epithelial cells 
(Hershberg & Mayer，2000) or dendritic cells (DCs) (Rescigno et al., 2001). 
These cells serve as APCs as they process and present allergenic fragments 
to naive T cells in the gut-associated lymphoid tissue (GALT). In the 
presence of IL-4 and other Th2 associated cytokines, these naive T-helper 
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cells (ThO) cells differentiate into the Th2 subset (Abehsira-Amar et al., 
1992). Th2 cells are characterized by the production of IL-4, IL-5, IL-9 and 
IL-13 (Mosmann & Coffman, 1989; Prioult & Nagler-Anderson，2005). As 
mentioned above, oral tolerance is ultimately induced in healthy individuals. 
Instead, an exaggerated Th2 response is exhibited in food allergic patients. 
IL-4 and IL-13 released into the cellular environment interact with receptors 
on T cells and trigger a biochemical cascade that leads to the activation of 
transcription factors signal transducer and activator of transcription 6 
(STAT6) (Takeda et al., 1996) and GATA-3 (Ting et al., 1996). STAT6 has a 
regulatory role in IL-4 signalling, while GATA-3 is involved in directing the 
development of T cells towards Th2 lineage by inhibiting IFN-y production, 
activating IL-4 promoter (Zheng & Flavell, 1997) and regulating IL-5 and 
IL-13 expression (Zhang et al., 1999; Pai et al., 2004). This further increases 
the levels of IL-4 and IL-13 in the microenvironment and hence intensifies 
the Th2 responses. These two cytokines can promote isotype switching 
towards IgE production by B cells from allergic patients (Van der Pouw 
Kraan et al., 1998; Vercelli et al , 1990). IgE then binds to its high affinity 
receptors (FceR) on mast cells (Tkaczyk et al., 2004). Upon subsequent 
ingestion of food allergens, the dietary proteins are processed and presented 
as allergenic fragments on major histocompatibility complex class II (MHC 
II) (Blumberg et al., 1999; Hershberg & Mayer，2000; Mayer, 1998) as in the 
first exposure. These fragments interact directly with allergen-specific IgE 
bound on mast cells. Cross-linking of these IgE antibodies then triggers the 
release of mediators, such as histamine, leukotriene, and chemokines. (Galli 
et al., 2005) that leads to allergic symptoms (Marone et al., 2003). On the 
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other hand, antigen presented by APCs to antigen-specific Th2 cells leads to 
rapid T-cell activation, proliferation and Th2 type cytokine production. Other 
than APCs, activated mast cells also produce Th2 type cytokines (IL-3, IL-5 
and IL-13). These cytokines lead to activation and accumulation of 
eosinophils and other inflammatory cells causing allergic inflammation in 
patients (Lorentz et al.，2000). Furthermore, eosinophils are not only 
involved in inflammation, but they also function as APCs that further 
promote expansion of Th2 cells in inflamed tissues (Shi, 2004). Due to 
inflammation response, diminished barrier integrity is observed leading to an 
antigen-induced enhanced epithelial permeability (Crowe & Marsh” 1993). 
This further increases the concentration of intact food allergens in the 
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Figure 2.1 Mechanisms of food allergy during the sensitization and 
effector ("second contact，，）phases. Food allergens were absorbed, processed 
and presented to naive T-helper (Th) cells. In the presence of IL-4, these cells 
differentiate into Th2 cells that secrete IL-4 and IL-13. These cytokines 
mediate the isotype switching in B cells towards IgE production. IgE 
antibodies then bind to mast cells. Upon subsequent exposure, interaction of 
allergen with IgE on the mast cell triggers the mediator release leading to 
clinical symptoms (Modified from Prioult & Nagler-Anderson, 2005). 
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2.5 Studies on seafood allergies and allergens 
Seafood allergy is one of the common forms of food allergies in many 
developed countries (likura et al, 1999; Oh et al., 2004; Sampson, 2004). 
Generally, seafood comprises fish, crustaceans and molluscs. Among various 
seafood, crustaceans and molluscs, which are collectively named as shellfish, 
is the more common causative food in the adult allergic patients in the 
United States (Sicherer et al., 2003). As mentioned, allergies to shellfish are 
even more frequently reported in Asian populations (Smit et al., 2005; Thong 
et al., 2007). It is believed that the worldwide prevalence of seafood allergy 
is associated with the increased supply and consumption of seafood (Lehrer 
et al., 2003). In addition, allergies to seafood are generally considered as 
life-long disorders once the allergic reactions are established in patients. Due 
to its prevalence and persistency, many efforts have been put in investigating 
seafood allergy. The following discussion is mainly summarized from two 
review papers on seafood allergy (Lehrer et al., 2003; Chu et al., 2005). 
Ingestion of seafood can induce a range of allergic reactions that are the 
typical types of responses observed in other forms of food allergies. The 
common clinical symptoms of seafood allergy are generalized itching, 
urticaria, swelling of lips and tongue, difficulty in breathing, diarrhea and 
abdominal pain, and even anaphylaxis. It is widely accepted that these 
responses are due to the development of IgE antibodies. It is believed that 
various forms of IgE-mediated allergic disorders share a similar pathological 
mechanism, which has been discussed in detail in the previous section. In 
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brief, when a seafood allergen successfully crosses the intestinal mucosa in 
an immunologically active form, it is recognized, processed and presented by 
various APCs. Presenting antigens to T and B cells stimulates the production 
of Th2 related cytokines and allergen specific IgE antibodies respectively. In 
subsequent exposure of the allergen, cross-linking of IgE bound onto the 
surface of mast cell leads to the release of mediators. These reactions 
contribute to the clinical symptoms observed in patients after exposure of 
seafood. Other than oral sensitization, direct contact with seafood products as 
well as inhalation of seafood or water droplets generated during food 
processing can also induce allergic reactions in seafood processing workers. 
These workers developed various clinical symptoms, including asthma, 
rhinitis or some sort of skin rash (Jeebhay et al., 1991). It is now widely 
accepted that both routes of exposure can lead to IgE production which 
results in allergic reactions. 
Other than the studies on immunological mechanism of seafood allergy, 
many investigations on the identification of allergens in common causative 
seafood, including fish, crustaceans and molluscs were also carried out. 
Parvalbumins are the major allergens found in the fish muscles 
(Ree-Kim & Lehrer，2004). The allergen Gad c 1 was first identified in 
Atlantic cod (Aas, 1967; Aas & Jebsen，1967; Elsayed & Apol, 1983). It 
consists of 113 amino acids and a glucose molecule, with a molecular weight 
of approximately 12 kD. The allergen belongs to a family of parvalbumin 
proteins that regulate calcium flow in muscular sarcoplasm of the white meat 
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(Wild & Lehrer，2005). Further studies have identified and cloned 
parvalbumin proteins from a number of fish species, including Salmo salar 
(Lindstrom et al., 1996) and Cyprinus carpio (Bugajska-Schretter et al., 1999; 
Swoboda et al” 2002). 
Tropomyosins have been identified as the major shrimp allergen. 
Tropomyosins are a family of actin filament-binding proteins that are 
essential in muscle contraction. The cloning of the major shrimp allergen 
from Metapenaeus ensis. Met e 1; was first reported by screening a cDNA 
library of shrimp muscle with sera from shellfish allergic patients (Leung et 
al., 1994). The cDNA of Met e 1 exhibited an open reading frame of 281 
amino acid residues, coding for a 34 kD protein. Another shrimp allergen, 
Pen a 1，was also successfully cloned from the shrimp Penaeus aztecus 
(Reese et al., 1997). There is a high amino acid sequence homology between 
the two recombinant shrimp allergens (Chu et al., 2005). On the other hand, 
tropomyosins have also been characterized as the major allergens in other 
crustacean species. Allergens Pan s 1 from the spiny lobster Pamdirus 
stimpsoni, Horn a 1 from the American lobster Homarus americanus, and 
Cha f 1 from the crab Charybdis feriatu were cloned and identified (Leung et 
al., 1998a，b). These three allergens have similar molecular weight as Met e 1 
(34 kD) and their deducted amino acid sequences are highly homologous to 
shrimp tropomyosin (Chu et al., 2005). These molecular evidences suggested 
that tropomyosins, with molecular size between 34 - 38 kD, are the major 
cross-reactive allergens among crustaceans. Despite the molecular analysis, 
cross-reactivity of crustacean allergens has also been well documented in 
I 
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clinical studies (Lehrer, 1986). While shrimp-allergic individuals showed 
allergic reactions to lobster, crab and crawfish, over 80% of them exhibited 
positive skin prick test responses to lobster and crab (Daul et al., 1987). 
Leung et al. (1996; 1998a，b) demonstrated that IgE reactivity to crude 
crustacean extracts was inhibited when the sera were pre-incubated with 
recombinant allergens, Met e 1，Pan s 1 or Horn a 1. These evidences clearly 
demonstrate that tropomyosins are the major allergen responsible for 
cross-reactions in crustaceans. To further characterize the IgE epitope in 
tropomyosins, a number of studies on shrimp tropomyosin, Pen a 1，were 
carried out (Ayuso et al., 2002; Reese et al., 1997; 1999). Reese et al. (1997) 
identified four IgE-binding regions in Pen a 1. In a more recent study, Ayuso 
et al. (2002) identified cross-reactive epitopes among shrimp, lobster, 
cockroach and house dust mites. This finding further emphasizes the 
homologous amino acid sequence of invertebrates which provides the basis 
of cross-reactions among them. Although IgE-binding epitope of shrimp 
tropomyosin has been identified, T cell epitopes remain to be elucidated in 
future studies. 
Recently, a novel allergen from the black tiger shrimp Penaeus 
monodon was cloned and identified as Pen m 2 (Yu et al., 2003). The cDNA 
contained 1071 bp of open reading frame encoding a 356 amino acid protein 
with a molecular weight of approximately 39.9 kD. The sequence of this 
protein showed 60% similarity to arginine kinase of crustacean species, 
including Penaeus japonicus’ Homarus gammarus and Procambarus clarkii. 
Being reactive to IgE from shrimp allergic patients, it is identified as a new 
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crustacean allergen. 
Molluscs are another type of commonly consumed seafood. There have 
been a number of reports on allergies to molluscs, such as allergies to 
abalone (Morikawa et al., 1990)，oyster (Nakashima, 1969)，limpet (Carrillo 
et al., 1991)，cuttlefish (Shibasaki et al , 1989) and squid (Carrillo et al., 
1992). Leung et al. (1996) showed that sera from individuals allergic to 
shrimp reacted with a 38-kD protein in various mollusc species. Inhibition 
assay indicated that IgE reactivity was inhibited when sera was pre-incubated 
with recombinant shrimp tropomyosin Met e 1. This identified the role of 
tropomyosins as allergens in molluscs. Subsequently, allergens from the 
abalone Ha Hot is divers icolor, the mussel Perna viridis, and the scallop 
Chlamys nobilis, were cloned and identified as tropomyosins of molecular 
weight ranged between 35 and 38 kD (Chu et al., 2000). IgE reactivity to 
these recombinant proteins was clearly demonstrated. Comparison of the 
amino acid sequences of tropomyosins of these three mollusc species with 
those from the GenBank database show that they share a similarity of 68% 
(Chu et al., 2005). 
In sum, crustacean and mollusc tropomyosins belong to a family of 
highly conserved proteins that show a significant degree of amino acid 
sequence homology (Ree-Kim & Lehrer，2006). This highlights the clinical 
relevance of cross-reactivity of tropomyosins in the induction of allergic 
responses. 
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2.6 Use of animal models in the study of food allergy 
Numerous animal models of various food allergies have been developed, 
such as murine models of peanut allergy (Li et al., 2000), cow's milk allergy 
(Li et al., 1999), rat model of egg allergy (Knippels et al, 1999)，and canine 
model of cow's milk allergy (Ermel et al., 1997). Experimental animal 
models have become important tools for the study of food allergy, especially 
in situations when target organs are inaccessible, such as the gastrointestinal 
tract in food allergy (Untersmayr & Jensen-Jarolim, 2006). Obviously, due to 
ethical and safety reasons, sensitization studies in human subjects are not 
possible. Animal models thus serve as the best alternative as they can mimic 
the immune responses of allergic patients, such as allergen-specific IgE 
production, histamine release and Th2-type cytokine responses. In fact, 
successfully mimicking human allergic reactions is the most important 
criteria for determining whether the model developed is useful or not. In 
order to achieve this aim, careful consideration on several parameters, such 
as selection of species and strain, age at first exposure, concentration of food 
allergen, route and duration of allergen exposure, and use of adjuvants, have 
to be taken in consideration (Untersmayr & Jensen-Jarolim，2006). 
2.6.1 Selection of species and strain for developing animal models 
Rodents are commonly used for developing models of food allergy. The 
popularity may be due to the following advantages (Untersmayr & 
Jensen-Jarolim, 2006): (1) its small body size for the ease of handling, thus 
22 
facilitating large experimental population and (2) the availability of a wide 
range of strains including transgenic animals for knockout experiments. It is 
suggested that Brown Norway rats are especially suitable for food 
sensitization protocols (Untersmayr & Jensen-Jarolim，2006) as they are high 
IgE responders (Knippels et al., 1999; Pilegaard & Madsen，2004) and thus 
resemble IgE production in atopic subjects. Other than the rat model, mice 
were adopted in numerous models (Dearman et al., 2001; Li et al., 1999; 
2000; Untersmyr et al” 2003). They are a valuable tool in the solving 
allergological questions as their • responses can mimic those in allergic 
patients and some aspects, for example, polarization of T cell response, are 
more prominent in mice (Finkelman et al, 2005; Mosmann et al, 1986; 
Untersmayr & Jensen-Jarolim, 2006). In addition, knockout mice can serve 
as in vivo model in functional study of the components in the immune system, 
which will be discussed in more details. 
Other than the selection of type of rodents, the strain used is also a 
factor influencing the development of successful models. There is no 
consensus in the response to allergens among different strains. It was shown 
that C3H/HeJ mice are more susceptible in developing allergic responses 
than BALB/c mice after sensitization with cow's milk or peanut allergens 
(Morafo et al., 2003). However, many reports also show that BALB/c mice 
can mimic human allergic responses well, both in humoral and cellular 
aspects (Adel-Patient et al., 2003; 2005; Navuluri et al., 2006; Strid et al., 
2004; Untersmayr et al” 2003). As stated above, the variation of responses 
may be due to differences in genetic background of mouse strains. Strain 
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selection must be considered in developing models of different food 
allergies. 
While murine models predominate the literature with respect to animal 
models of food allergy, studies of natural allergic responses in atopic dog 
(Buchanan & Frick，2002) and neonatal swine model (Helm et al., 2002) and 
experimentally induced allergy in canine model (Ermel et al., 1997; Teuber 
et al., 2002) also contribute to knowledge about food allergy. These models 
may be more advantageous over, the rodent model in some areas. It is now 
known that the canine genome shares approximately 75% homology with the 
human genome and is more closely related genetically to human than the 
rodent species commonly used in research (Kirkness et al., 2003). 
Furthermore, interventional tests, like endoscopic analysis and gastroscopic 
food challenge, are easier to be performed in larger animals (Untersmayr & 
Jensen-Jarolim, 2006). Therefore the canine model is postulated to be 
appropriate for detecting hidden food allergens and testing allergenicity of 
genetically modified food (Frick, 1996; Teuber et al , 2002). The swine 
model presents several important advantages over other animal models for 
the study of pathogenesis of food allergy. Their gastrointestinal physiology 
and development of mucosal immunity closely resemble those in human 
(Phillips & Tumbleson，1986). On the other hand, similarity in intestinal 
anatomy and nutritional requirements between developing piglets and infants 
allow studies on the relationship of digestive enzymes activities and 
development of components of gut barrier with food allergy (Phillips & 
Tumbleson, 1986). In addition, swines are bom immunocompetent and thus 
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assessment of their immune responses is allowed (Phillips & Tumbleson， 
1986). However, due to their large body size and difficulty in handling, 
application of these animal models is limited. 
2.6.2 Parameters of sensitization protocol 
The age of animals at first exposure, allergen concentration, route and 
duration of exposure and use of adjuvant are the parameters that account for 
the success in eliciting immune response to allergens in animal models. It is 
believed that the younger the animal, the better the sensitization response. 
Similar to young children, the intestinal mucosa of younger animals is not 
completely developed and is more permeable to food substances. Various 
studies demonstrate that hypersensitive responses were only successfully 
established when allergen was first introduced to mice at young age, for 
instance, immediately after birth (Strobel & Ferguson，1984) or three weeks 
after birth (Li et al., 2000). In both studies, feeding allergen to mice after 
reaching adulthood would only induce oral tolerance, but not allergic 
reactions. Similar observation was made in our laboratory. BALB/c mice 
showed a significant IgE production when they were first sensitized with 
shrimp tropomyosin at the age of three weeks (Tang, 2004). This study also 
demonstrates that the dosage of allergen is another critical factor in inducing 
responses in mice. The result showed that sensitization with 0.1 mg shrimp 
tropomyosin, but not 1 mg of the protein, could generate allergic responses, 
as indicated by the serological IgE level in mice. This may be due to the 
induction of high-dose tolerance in mice. This phenomenon is in accordance 
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with findings in mouse model of peanut allergy (Li et al., 2000). This study 
demonstrates that feeding C3H/HeJ mice with 5 mg of ground whole peanut 
would induce higher IgE levels and more severe allergic reactions than 
feeding with 25 mg of peanut. 
Besides the age of animals and allergen dose, the route of exposure may 
also affect the effect of sensitization. Studies showed that intragastric (Li et 
al., 1999)，intraperitoneal (Dearman et al., 2000)，subcutaneous (Li et al., 
2003) or epicutaenous (Hsieh et al., 2003) administration of food allergens 
can elicit immune responses in animals. However, intragastric gavage is the 
most recommended avenues (Helm, 2002) as it best resembles the site of 
sensitization in human subjects. 
The last parameter to be considered is the use of adjuvant. 
Co-administration of food antigens and adjuvant enhances uptake and 
presentation of food antigens (Bromander et al., 1991). Cholera toxin was 
one of the common adjuvants used for oral sensitization in various murine 
models (Adel-Patient et al., 2005; Li et al., 2000; van Wijk et al., 2004). 
Similar to other researches, Tang (2004) also demonstrated that mice could 
only be sensitized to shrimp allergen when immunization was administrated 
together with the toxin. It was found that this toxin not only helps in antigen 
uptake and presentation, but also in promotion of the Th2-type cytokine 
production in mice (Marinaro et al., 1995). 
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2,6.3 Lessons from animal models 
Animal models have been a useful tool for the study of food allergy as 
well as other forms of allergies. As stated above, these models allow 
sensitization study to be possible. This provides the basis for investigations 
on the underlying pathogenesis of food allergy, especially during early 
sensitization phase. Expanding the knowledge on mechanisms facilitates the 
development of new prophylactic and therapeutic strategies in preventing 
and curing this life-threatening disease (Knippels et al., 2004). 
2.6.3.1 Investigations on pathogenesis of food allergy 
J 
Studies on animal models significantly advance our knowledge on 
pathogenesis of food allergy. For example, associating breaking down the gut 
barrier with allergic sensitization is supported by animal model studies. 
Untersmayr et al. (2003) demonstrated exposure to antacids, medicine that 
hinder peptic digestion, induces sensitization to fish allergen in BALB/c 
mice. 
Mouse model studies also elucidate the underlying mechanism in 
determining the polarization of T cell responses. For example, genetic factor 
in association with Thl/Th2 balance is clearly demonstrated by two mouse 
strains, BALB/c and C3H/HeJ mice (Morafo et al., 2003). Due to the 
mutation in toll-like receptor in C3H/HeJ mice, Th2 response is more 
favoured in them. Use of transgenic mice further illustrates the interactions 
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of cytokines and cellular components of immune system during phases of 
allergic reactions. Knock-out mice were used for studying the role of various 
cytokines, such as IL-4/IL-5 (Kopf et al.，1993), IL-13 (McKenzie et al., 
1998) and IL-4/IL-13 (McKenzie et al., 1999) in Thl/Th2 polarization and 
IL-17 in T cell sensitization of airway hypersensitivity (Nakae et al., 2002) 
One of the recent groundbreaking studies is on the action of IL-5 and eotaxin 
in food allergic inflammation (Hogan et al, 2000). This is the first study to 
demonstrate that eotaxin is also involved in food allergy, not only in airway 
hypersensitivity. Other than knock-out mice, IL-4 (Tepper et al., 1990) and 
IL-5 (Dent et al., 1990) over-expressing mice may provide models for 
evaluating the efficacy of new therapeutic strategies. 
2.6.3.2 Studies on development of therapeutic strategies 
i 
At present, no satisfactory treatment for food allergy is available. The 
establishment of animal models may provide a tool for assessing therapeutic 
strategies. Feasibility of peptide immunotherapy has been studied in a mouse 
model of peanut allergy (Li et al., 2001). Mice were immunized with a 
mixtures of peptides, representing the entire sequence of major peanut 
allergen Ara h 2. These short peptides (10-20 amino acids) are recognized by 
T cells, but are too short to cross-link IgE antibodies bound onto mast cells, 
so that mast cells are not activated (Nowak-Wegrzyn & Sampson, 2004). 
This study shows that mice pre-treated with the peptide mixture did not show 
anaphylactic responses after challenge. 
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Mutated allergen protein immunotherapy is suggested as another 
immmunomodulatory therapy for food allergy. The allergen is mutated in a 
way that IgE-binding sites of allergen are eliminated. In vivo efficacy of this 
approach was tested in a murine model of peanut anaphylaxis (Srivastava et 
al., 2002). Sensitized mice were successfully desensitized after intranasal 
administration of mutated Ara h 2 as specific IgE level and allergic 
symptoms were decreased. 
Plasmid DNA-based immunotherapy was also assessed using murine 
model of peanut allergy (Srivastava et al, 2001). Although the mechanism of 
this immunotherapy remains unknown, immunization of immunostimulatory 
oligonucleotide (ISS)-conjugated Ara h 2 to peanut-allergic mice prevented 
the development of symptoms after oral challenge. It is suggested that this 
approach may also serve a prophylactic effect, which remains to be further 
investigated usirfg animal models. 
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Chapter 3 
Characterization of hypersensitive responses to 
recombinant shrimp tropomyosin in mice 
3.1 Introduction 
Food allergy is recognized as the commonest cause of anaphylaxis in 
many countries (see chapter 2). Shellfish is a common causative food 
substance in food allergic patients.. Shrimp is the most consumed food among 
different shellfishes (Fisheries Statistics and Economic Division, 2003). It is 
believed that high consumption of shrimp contributes to the prevalence of 
shrimp allergy (Ree-Kim & Lehrer, 2004). However, similar to other food 
allergies, no effective therapeutic strategies have been developed and strict 
avoidance of shrimp is the only choice for the patients. It is highly warranted 
that extensive study on shrimp allergy is necessary. Animal models serve as a 
useful tool for this kind of study. A murine model of shrimp allergy has been 
developed by sensitizing the mice with the recombinant shrimp tropomyosin, 
as described in a previous study in our laboratory (Tang, 2004). Since 
behavioural and humoral responses have been investigated extensively in 
that study, the present study mainly focuses on T cell responses in the 
allergic mice, including allergen-specific CD4+ proliferation and cytokine 
expression profile of re-stimulated splenocytes. 
The objectives of this chapter are to describe the preparation of 
recombinant shrimp tropomyosin from Metapenaeus ensis (rMet e 1) by 
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recombinant DNA technology, and to present the hypersensitive responses to 
the recombinant protein in mice. 
In this study, young BALB/c mice were orally sensitized and challenged 
with purified recombinant shrimp tropomyosin and cholera toxin. The 
shrimp tropomyosin-speciflc IgE level was measured throughout the course 
of this study. After challenge, allergic mice were sacrificed for characterizing 
T cell responses. Behavioural and morphological changes were also assessed 
before and after challenge. ‘ 
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3.2 Materials and Methods 
3.2.1 Preparation of the recombinant shrimp tropomyosin 
The expression, purification and quantification of recombinant shrimp 
tropomyosin from Metapenaeus ensis are presented as follows. 
3.2.1.1 Expression of the recombinant shrimp tropomyosin 
The shrimp tropomyosin, Met e I, was identified as IgE-reactive clone 
from the cDNA library of Metapenaeus ensis (Leung et al., 1994). The clone 
was originally transformed into a glutathione-S transferase (GST) plasmid 
system for expressing recombinant shrimp tropomyosin. It was then subcloned 
into a His-tag expression vector pQE30 in which tropomyosin was expressed 
as a His-tag fusion protein (Tang, 2004) by Escherichia coli Ml5 cells . It is 
more preferable to express the proteins with His-tag due to its small molecular 
size and low immunogenicity (Tang, 2004). Alignment of the nucleotide 
sequences confirmed that the sequence of inserts in the purified clone is 
identical as the sequence of Met e I deposited in the GenBank (Tang, 2004). 
The stock of transformed cells was kept frozen in glycerol under -20°C. 
To grow the bacteria, 500 jil of the bacterial stock was inoculated in 25 ml 
LB broth containing 25 |ig/ml kanamycin and 100 ^g/ml ampicillin at I T C 
overnight with shaking. For large batch culture of bacteria, the overnight 
culture was then incubated in 1 L LB broth containing 25 |ig/ml kanamycin and 
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100 jig/ml ampicillin at 37°C with shaking until an OD600 of 0.6 was reached. 
Isopropyl thiogalactose (DPTG) was then added to the bacterial culture, at a 
final concentration of 1 mM, for inducing the expression of recombinant 
protein overnight. The bacterial cells were harvested by centrifugation at 
10,000 rpm for 30 minutes. Cell pellet was subjected to three cycles of freezing 
and thawing before extraction. The pellet was stored at -20°C until use. 
3.2.1.2 Extraction and purification of the recombinant protein under native 
condition 
Recombinant fusion protein of His-tagged shrimp tropomyosin was 
purified using Ni-NTA agarose beads (QIAGEN) under native condition 
according to the manufacturer's instructions. In brief, the frozen cell pellet 
was thawed on ice for 15 minutes and resuspended in 8-10 ml lysis buffer (50 
mM NaH2P04, 300 mM NaCl, 10 mM imidazole, pH 8.0). Lysozyme 
(Img/ml) was added to the cell suspension and the mixture was incubated on 
ice for 30 minutes with gentle stirring. The mixture was sonicated on ice six 
times for 10 seconds each at 200W. The cell debris was removed by 
centrifuging the lysate at 10,000 rpm for 30 minutes at 4°C. The supernatant 
was collected and transferred to a column containing Ni-NTA slurry provided 
by the manufacturer (Ni-NTA: cell lysate =1:4) . The mixture was incubated 
at for one hour or overnight. The supernatant was then eluted from the 
column. One ml of supernatant was collected for SDS-PAGE analysis. 
Subsequently, the slurry was washed twice with 7 ml wash buffer (50 mM 
NaH2P04, 300 mM NaCl, 20 mM imidazole, pH 8.0) for removing 
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non-specific protein in the mixture. Similarly, one ml of wash buffer from 
each wash was collected. The column was further equilibrated with 0.5 ml 
elution buffer (50 mM NaHzPOg’ 300 mM NaCl, 250 mM imidazole, pH 8.0) 
before the collection of recombinant proteins. Finally, the specific 
recombinant protein was eluted out with one ml of elution buffer for seven 
times. 
3.2.1.3 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE) . 
Samples of cell lysate after centrifugation, eluent from column during 
washings, and eluent from column after addition of elution buffer were 
analysed by SDS-PAGE to check the purity of the extracted protein and to 
estimate the approximate molecular size of the extracted protein. Ten [il of 
each sample was mixed with 10 \i\ 2x sample buffer (3.0 g Tris, 14.8 g 
EDTA，4 g SDS, 10 ml 2-mercaptoethanol, 20 ml glycerol, 40 mg 
bromophenol blue, pH 6.8 in 100 ml ddHsO) and denatured at 95°C for five 
minutes. The protein samples were analysed by SDS-PAGE on 4% stacking 
gel (1.25 ml of 0.5 M Tris at pH 6.8，2.85 ml ddH�。，50 10% SDS, 37.5 
10% ammonium persulfate, 5 [l\ N，N,N,，N’-tetramethylenediamine [TEMED] 
and 0.85 ml 40% acrylamide/bis solution 19:1) and 12.5% separating gel (2.5 
ml of 1.5 M Tris at pH 8.8，4.0 ml ddHsO, 100 i^l 10% SDS, 75 10% 
ammonium persulfate, 10 |il TEMED and 4.25 ml 40% acrylamide/bis 
solution 19:1). 
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The gel was run at constant voltage of 120 V in Ix SDS-PAGE electrode 
running buffer, which was diluted from lOx SDS-PAGE electrode running 
buffer (30.3 g Tris, lOg SDS and 137.3 g glycine in 1 L ddHzO). 
Electrophoresis was stopped when the bromophenol blue dye just disappeared 
from the bottom of the gel (approximately 90 minutes). The molecular weight 
marker (Bio-Rad, low range SDS-PAGE standard) were run in parallel with the 
samples. Thereafter, the gel was then stained with Coomassie blue staining 
solution (2.5 g brilliant blue R, 70 ml acetic acid and 400 ml methanol in IL 
ddHzO) for 15 minutes with shaking. It was then destained in destaining 
solution (250 ml methanol, 50 ml acetic acid in 200 ml ddHaO) for 15 minutes 
with shaking. The gel was finally cleaned in cleaning solution (10% acetic acid 
in ddH20) overnight with shaking. The image of the gel was captured by 
scanning. 
3.2.1.4 Quantification of the recombinant protein and detection of level of 
endotoxin in the protein 
After confirming that the extracted protein was of the target molecular 
weight, it was further purified by dialyzing the recombinant protein in 
dialysis tubing with 10 kDa molecular weight cutoff. The protein was 
dialysed in 3 L Ix PBS overnight at The purified protein was then 
collected and the protein concentration was determined by standard BCA 
method. Bovine serum albumin (BSA; PIERCE) was used as a standard 
protein for estimating the concentration of tropomyosin in the solution. 
Subsequently, the presence of endotoxin in the protein solution was detected 
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using Pyrotell Limulus Amebocyte Lysate (LAL) kit (Associates of Cape 
Cod Inc.). The remaining solution was stored at -70�C until they were frozen. 
The frozen protein solution was lyophilized under vaccum at -200°C into 
powder form. The powder was then be stored at -20°C or resuspended in 1 x 
PBS solution for immunizing the mice. 
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3.2.2 Characterization of hypersensitive responses in mice 
3.2.2.1 Mice 
Three- to four-week-old female BALB/c mice were acquired from the 
Laboratory Animal Services Centre (The Chinese University of Hong Kong, 
HKSAR) for this study. The mice were maintained on shrimp-free chow 
under hygiene environment. Standard guidelines for animal care and use of 
animal were followed. This study is carried out under the approval of Animal 
Experimentation Ethics Committee of the University and the Department of 
Health, Government of Hong Kong Special Administrative Region. 
3.2.2.2 Sensitization and challenge of mice 
Three groups of mice were included in this study with 6-13 mice in 
each group. In the treatment group, mice (n=13) were intragastrically 
sensitized and challenged with tropomyosin plus cholera toxin (CT) as 
adjuvant. Two control groups were studied in parallel, of which one group 
(n二8) were fed with Ix PBS plus CT, and the other group (n=6) were fed 
with 0.1 mg of 6x histidine peptides plus CT. The peptide was synthesized 
using a peptide synthesizer (Applied Biosystems 433A). Since all materials 
used to feed the mice were dissolved in Ix PBS, PBS-fed mice were used as 
one of the control groups to determine whether the induced immune 
responses was due to the presence of shrimp tropomyosin or otherwise. 
Similarly, histidine peptides were given to the mice as the recombinant 
protein used was expressed together with histidine-tag. Including this control 
group helped to eliminate the effect of histidine molecules produced in the 
mice. 
The experimental protocol mainly followed the procedures as described 
by Tang (2004)，but with some modification on the interval of sensitization 
as some difficulties in sensitizing mice were encountered in the early phase 
of the present study. Tang (2004)’s study was conducted in Taiwan. It was 
suspected that the difference in laboratory environment between Taiwan and 
Hong Kong and the genetic background of mice might result in the 
discrepancy. The protocol is summarized in Fig. 3.1. In brief, mice in 
treatment group were sensitized intragastrically with 0.1 mg recombinant 
shrimp tropomyosin plus CT on days 0，12，19 and 26, instead of a weekly 
basis. Mice were fasted overnight and were challenged with 1.0 mg shrimp 
tropomyosin plus CT on day 33. The two controls were studied in parallel. 
3.2.2.3 Assessment of systemic anaphylaxis responses 
Systemic anaphylaxis responses were evaluated by close observation of 
mice for 30 to 40 minutes after challenge on day 33. The assessment was 
done based on a scoring system as described (Li et al., 2000): 0 - no 
symptoms; 1 - scratching and rubbing around the nose and head; 2 -
puffmess around the eyes, pilar erecti, reduced activity, and/or decreased 
activity with increased respiratory rate; 3 - wheezing, laboured respiration, 
cyanosis around the mouth and the tail; 4 - no activity after prodding, or 
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tremor and convulsion; and 5 - death. 
3.2.2.4 Detection of shrimp tropomyosin specific IgE level 
Blood was collected from tail vein on days 0，19，26, 33 and 39 for 
monitoring the shrimp tropomyosin-speciflc IgE level in mice (Fig. 4.1). 
Sera were collected by centrifugation at 10,000 rpm in room temperature. 
Sera collected were stored in -20^C before analysis. Shrimp 
tropomyosin-speciflc IgE level in sera was determined by ELISA. Briefly, 
plates (Maxisorp, Nunc) were coated overnight at 4°C with 10 |ig/ml 
recombinant shrimp tropomyosin in carbonate coating buffer (0.05 M 
Na2C03，0.13 M NaHCOs, 0.003 M NaNs, pH 9.6). The plates were then 
washed with PBS solution twice and blocked with 3% bovine serum albumin 
(BSA; Sigma) in PBS for 2 hours. After two washings with PBS/0.05% 
Tween-20, diluted serum samples (1/10 dilution in 3% BSA-PBS) were 
added to the plates and incubated overnight at 4°C. Plates were washed four 
times, followed by incubation with 100 i^l of 1 jig/ml biotin-conjugated 
anti-mouse IgE (Pharmingen) for 45 minutes. The plates were kept in 
darkness with aluminium foil for protection. After washing for 6 times, 100 
|il of 1 fxg/ml avidin peroxidase (PIERCE) was added and incubated for 30 
minute in darkness. The plates were washed eight times, developed with 
2,2-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS; Sigma) solution 
(0.05% ABTS, 0.03% H2O2, 0.24 M citric acid monohydrate, 0.05M 
Na2HP04, pH 4.2) for 30 minutes and read at 415 nm using a microplate 
reader. All the incubations were carried out at room temperature, unless 
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otherwise stated. All assays were performed in duplicate. 
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3.2.2.5 Passive cutaneous anaphylaxis (PCA) test 
The procedures described by Ovary (1990) were followed with some 
modifications. Sera from two or three mice in each group were collected 
after challenge and pooled to a total volume of 100 |il. Three naive BALB/c 
mice of six weeks old were anesthetized by i.p. injection with 10% ketamine 
and 10% xylazine in sterile PBS. The back of the mouse was sprayed with 
70% ethanol before shaving. Undiluted pooled sera from each group of mice 
and heat inactivated sera from sensitized mice (inactivated at 56°C for 3 
hours) were injected intradermally at the back. Injection of Ix PBS solution 
served as sham to indicate the damage due to injection. Twenty-four hours 
later, mice were injected intravenously with a mixture of 250 |il of 0.5% 
Evan's blue dye and 250 \ig recombinant shrimp tropomyosin. Thirty 
minutes after dye-antigen administration, the mice were killed and the skin 
on their backs was immediately inverted. Reactions were examined for 
visible blue colour. A reaction was scored as positive if the blueing of the 
skin at the site of injection was greater than one cm in diameter in any 
direction. 
3.2.2.6 In vitro proliferation assay under stimulation of shrimp 
tropomyosin 
Six days after challenge, mice were bled and sacrificed by dislocating 
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the spine from brain at the neck. Spleens were harvested immediately from 
each mouse of the three different groups. The isolated spleens were then put 
into 0.2% BSA in Ix PBS solution (0.2% BSA-PBS) and kept in ice. 
Splenocytes were obtained from the spleen by mincing with syringe. The 
mixture was allowed to stand in ice for five minutes. Supernatant was 
collected and centrifuged at 1500 rpm for ten minutes at 4°C. Cell pellet was 
collected and incubated with one ml of lysis buffer (0.15 M NH4CI, 1 mM 
KHCO3, 0.1 mM Na2-EDTA, pH7.2, 0.22 |im filtered) for one minute on ice 
to remove the erythrocytes from the suspensions. The lysis process was 
stopped by adding nine ml of Hank's Balanced Salt Solution (HBSS; Sigma). 
The cells were centrifuged at 1500 rpm for ten minutes at 4°C. Supernatant 
was discarded and the cell pellet was washed twice by resuspending it in ten 
ml 0.2% BSA-PBS, followed by centrifugation at 1500 rpm for seven 
minutes at 4°C. The cells were then resuspended in 0.2% BSA-PBS. The 
viability of harvested splenocyte was checked using hemocytometer. Ten i^l 
of cell suspension was mixed with 40 |il of tryphan blue solution. The 
mixture was added into a hemocytometer for counting the number of viable 
cells. After determining the concentration of viable cells, 4x10^ splenocytes 
were suspended in 500 of 0.2% BSA/PBS and incubated with 500 of 
5-(and-6)-Carboxyfluorescein diacetate succinimidyl ester (CFSE) at a 
labelling concentration of 10 |iM in darkness for 8 minutes at room 
temperature. After two washings with HBSS, splenocytes were resuspended 
in complete culture medium of RPMI-1640 (Sigma) containing 10% fetal 
bovine serum and 1% penicillin/streptomycin. CFSE labelled splenocytes (2 
X 106 spleen cells/ml/well) were cultured in 24-well plates (Nunc) in the 
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presence or absence of recombinant shrimp tropomyosin (100 |ig/ml). Cells 
stimulated with 10 |j.g/ml phytohemagglutinin (PHA) and 50 |ig/ml BSA 
were included as positive and negative controls respectively. The splenocytes 
were incubated at 3TC in 5% CO2 for eight days. Subsequently, cells were 
harvested by centrifuging at 1500 rpm for 10 minutes at 4°C. The 
supematants were collected for analyzing cytokine production from these 
stimulated splenocytes. The cell pellets were resuspended in 100 \i\ of FACS 
medium (2%v/v heat inactivated fetal bovine serum, 0.05%v/v NaNs in Ix 
PBS solution). 2 jxl of mouse IgG (10 \ig/m\) was added and incubated in ice 
for 30 minutes with occasional gentle shaking. After washing with FACS 
medium, the cells were stained in darkness with anti-CD4-phycoerythrin 
(anti-CD4-PE; BD Pharmingen) at a working concentration of 2.5 |ig/ml for 
30 minutes in ice. After washings twice with FACS medium, stained cells 
were analyzed by five-color flow cytometry on FACS vantage (Becton 
Dickinson) using CellQuest software. After compensating analysis of CFSE 
and PE intensities, the frequencies of dividing CD4+ cells were calculated 
based on flow cytometric analysis of CFSE intensity gated on CD4+ cells. 
3.2.2.7 Cytokine profile of splenocytes 
Splenocyte suspensions of individual mouse were prepared as 
described above. After eight days of incubation, supematants from 
splenocyte cultures of various groups of mice were collected and stored at 
-70°C until analysis. Pooled supematants from three or four mice in each 
group were used to study the expression profile using mouse cytokine 
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antibody array kit (Ray Biotech Inc.) according to the user's manual. 23 
different cytokines and chemokines antibody was dotted in duplicate on a 
membrane. Six spots of HRP-conjugated antibody served as a positive 
substrate control and for identifying the orientation of the membrane. The 
membrane was first blocked with Ix blocking buffer provided by the 
manufacturer for 30 minutes at room temperature, and then incubated on a 
shaker with one ml of pooled culture supernatant overnight at 4°C. The 
membrane was washed three times with Ix Wash Buffer I，followed by two 
times of washing with Ix Wash Buffer II. The two wash buffers were 
provided by manufacturer. The membrane was washed for five minutes each. 
One ml of diluted biotin-conjugated anti-cytokines (provided by 
manufacturer) was added to a membrane and incubated on a shaker for two 
hours. After washings, the membrane was incubated with a 1:1000 dilution 
of Horseradish peroxidase (HRP)-conjugated streptavidin for two hours. The 
membrane was washed and developed with 500 [i\ of peroxidase substrate 
(provided by manufacturer) for one minute. All the washing and incubation 
steps were carried out at room temperature, unless otherwise stated. The 
assay was duplicated for each group of mice using two different membranes. 
The array image was captured with a chemiluminescence imaging system. 
The intensities of dots were semi-quantified based on a grey scale using 
Kodak image analysis software. The intensity of each spot was determined 
by subtracting the mean background grey level from the mean intensity. 
In parallel, levels of IL-4 and IFN-y from each supernatant sample were 
quantified using ELISA development kit (ELISA Duoset, R& D Systems) 
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according to the manufacturer's instructions. Briefly, capture antibody 
provided by the manufacturer was resuspended and diluted to a final 
concentration of 4 ^g/ml with Ix PBS. Plates were coated with diluted 
capture antibody overnight at 4°C. The plates were then washed with 
PBS/0.05% Tween 20 for three times and blocked with 1% BSA-PBS for 2 
hours. The plates were incubated overnight at 4°C with 100 \i\ of culture 
supematants from individual splenocyte culture. Meanwhile, detection 
antibody was resuspended and diluted to a final concentration of 400 ng/ml 
with 1% BSA-PBS. After washings for three times，100 pi of diluted 
detection antibody was added and incubated for two hours. After washings, 
100 |il of streptavidin-HRP (dilution was done according to the 
manufacturer's instructions specified on the bottle) was added and incubated 
for an hour in darkness. Finally, the plates were washed, developed with 
substrate solution provided by the manufacturer for 30 minutes and read at 
450 nm using a microplate reader. All the incubations were carried out at 
room temperature, unless otherwise stated. All assays were performed in 
duplicate. 
3.2.2.8 Histological examination of small intestine 
Histological changes of small intestine were assessed by examination of 
jejunum region of small intestinal samples (3-5 cm away from stomach) 
collected either 24 hours or six days after challenge. Tissues were fixed in 
methanol/formalin (1:1) for two to three hours, and embedded with paraffin. 
Five |im thick of paraffin sections were cut and stained with 
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hematoxylin-eosin stain. The responses were scored as positive allergic 
symptoms if the following parameters were clearly observed in most parts of 
the tissue sections: (1) reduction of length of villi, (2) sloughing of 
enterocytes, (3) edema of lamina propria, and (4) infiltration of lymphocytes 
into lamina propria or epithelial layers. 
3.2.2.9 Statistical analysis 
The data in the IgE level were presented as mean 士 SE，while those in in 
vitro proliferation of splenocyte and ELISA of cytokines (IL-4 and IFN-y) 
are presented as data from individual mouse, with a horizontal bar 
representing the median in each group of mice. The statistical significance of 
the data was determined by Kruskal-Wallis One Way Analysis of Variance on 
Ranks, followed by Dunn's pairwise multiple comparison procedure 
(SigmaStat 3.0). A/? value of <0.05 was considered significant. 
f 
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Figure 3.1 Experimental protocol. BALB/c mice were sensitized 
intragastrally with recombinant shrimp tropomyosin and cholera toxin (CT) 
on days 0，12, 19 and 26. They were fasted overnight and challenged on day 
33. Mice fed with either PBS plus CT or histidine peptides plus CT were 
studied in parallel as the controls. Blood samples were collected on days 0, 
19, 26, 33 and 39 (open arrows). Mice were bled and sacrificed after six days 




3.3.1 Preparation of the recombinant shrimp tropomyosin 
SDS-PAGE of eluent samples collected after the addition of elution 
buffer showed a band of approximately 34 kDa (Fig. 3.2). This band 
corresponded to the recombinant shrimp tropomyosin from Metapenaeus 
ensis extracted from the bacterial culture. The band was first observed in the 
cell supernatant after centrifugation. Due to the presence of His-tag in the 
recombinant protein, target recombinant protein could strongly bind to the 
Ni-NTA agarose bead, while non-specific impurities should be washed away. 
A protein mixture was present in the wash buffers, but only a very little 
amount of recombinant shrimp tropomyosin was washed away. Most of the 
recombinant shrimp tropomyosin was eluted out in the elution buffer. In 
addition, BCA assay showed that the yield of recombinant protein after 
dialysis ranged from 0.2 mg/ml to 1.2 mg/ml. Furthermore, the LAL kit 
demonstrated undetectable level of endotoxin in the protein. This indicates 
that the purified shrimp tropomyosin is free of endotoxin, and thus it is safe 
for sensitizing mice in the latter part of this study. 
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Figure 3.2 SDS-PAGE of protein samples obtained after induction and 
during purification steps. Lane 1: Supernatant of cell lysates after sonication 
and centrifugation; Lane 2: Eluent collected after first washing; Lane 3: 
Eluent collected after second washing; Lane 4: Eluent collected after 
addition of elution buffer and Lane 5: Recombinant protein obtained after 
dialysis; Marker (on the right): low range protein ladder (Bio-Rad). 
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3.3.2 Induction of systemic anaphylaxis responses after challenge 
Systemic anaphylactic responses were observed after the challenge on 
day 33. After challenge, all the 13 sensitized mice had symptoms of 
scratching around nose and tail (Fig. 3.3). In addition, seven of them also had 
both the cutaneous reaction with puffmess around eyes and mouth and 
laboured respiration. The symptoms became obvious in the sensitized mice 
I 
15-20 minutes after challenge and peaked at 30-40 minutes. None of the 
control mice showed any symptoms of anaphylaxis during the course of 
sensitization and challenge. 
3.3.3 Elevated level of shrimp tropomyosin specific IgE 
Elevations in shrimp tropomyosin-specific IgE level were observed in 
mice after sensitization on days 19 and 26 and challenge on day 33 (Fig. 3.4). 
Based on statistical analysis, tropomyosin-specific IgE level in sensitized 
mice is higher than the control mice on days 19，26 and 33 (p<0.001). High 
IgE level persisted in the sensitized mice for at least six days after challenge 
(day 39). In contrast, shrimp tropomyosin-specific IgE remained at a very 
low level in both controls. There are no statistical differences between the 
two control groups. These results demonstrated that the elevation in 
tropomyosin-specific IgE level is due to the feeding of shrimp tropomyosin 
to BALB/c mice. 
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3.3.4 Passive cutaneous anaphylaxis (PCA) reactions 
Diameters of the blueing region at different injection sites were assessed. 
Blue spots were observed at sites where pooled sera from sensitized mice, 
control mice fed with either PBS or histidine peptides, heat inactivated sera 
from sensitized mice or Ix PBS solution were injected (Fig. 3.5). Comparing 
these five spots, it was found that only injection of sera from sensitized mice 
produced a spot of diameter larger than 1 cm. This indicated only these sera 
could induce significant vascular leakage in naive mice. 
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Figure 3.3 Systemic anaphylaxis responses after intragastric 
challenge. Responses of the three groups of mice including sensitized mice 
fed with shrimp tropomyosin plus adjuvant (referred as ‘Trop’ group), 
control mice fed with Ix PBS plus adjuvant (referred as ‘PBS，group) or 
histidine peptide plus adjuvant (referred as ‘His’ group), were evaluated for 
30-40 minutes after challenge based on a scoring system: 0 - no symptoms; 
1 - scratching and rubbing around the nose and head; 2 - puffiness around the 
eyes, pilar erecti, reduced activity, and/or decreased activity with increased 
respiratory rate; 3 - wheezing, laboured respiration, cyanosis around the 
mouth and the tail. Numbers of mice in each group are indicated in 
parenthesis. Each open dot represents an individual mouse. 
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Figure 3.4 Serological level of recombinant shrimp tropomyosin-specific 
IgE in mice. Sera from different groups of mice (see legend of Fig. 3.3 for 
abbreviations of the groups) were collected on days 0，19, 26, 33 and 39. 
Number of mice in each group is shown in parentheses. The 
tropomyosin-specific IgE levels were determined by ELISA. Data are 
expressed as mean 士 SE. Asterisks indicate statistical differences between 
sensitized mice and the two control groups (p < 0.001). 
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Figure. 3.5 Passive cutaneous anaphylaxis (PCA) reactions. Pooled sera 
of different groups of mice (see legend of Fig. 3.3 for abbreviations of the 
groups) and heat inactivated sera from sensitized mice were injected 
intradermally into the mouse, followed by intravenous administration of 
recombinant shrimp tropomyosin with Evan's blue. Injection of IxPBS 
served as the sham control. Significant vascular leakage was observed in the 
region where sera from sensitized mice were injected. 
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3.3.5 Proliferation response of splenocytes under in vitro stimulation 
To characterize the responses of T cells to different antigens, 
proliferation was assessed by measuring the frequency of dividing CD4+ T 
cells in the cultures in the presence of different antigens. Representative 
intensity histograms showed the trend of proliferation level in various groups 
of mice under stimulation of different antigens (Fig. 3.6). Responses under 
stimulation of each antigen will be presented below. 
When phytohemagglutinin (PHA) was used as a positive control, 
proportion of dividing CD4+ T cells ranged from 5% to 20% (data not 
shown). This indicated that the cells harvested from different groups of mice 
were healthy and able to response to mitogen stimulation. 
When cultured with the recombinant shrimp tropomyosin, the 
proportion of dividing CD4+ T cells in the splenocyte cultures from 
sensitized mice ranged from 3.3% to 25.2% with standard error of 2.02% 
(Fig. 3.7). Statistical analysis showed that CD4+ T cells from sensitized mice 
had a higher proliferation level under in vitro stimulation of shrimp 
tropomyosin. Splenocytes from the two control mice showed a lower 
proliferation level, of which the mean proportion of dividing CD4+ T cells in 
the splenocyte cultures from PBS-fed and His-fed mice was 2.4% 土 0.60o/o 
and 3.06% 土 0.32o/o respectively. 
Under stimulation of bovine serum albumin (BSA), which served as an 
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irrelevant antigen, splenocytes from all groups of mice exhibited a very low 
proliferation (mean proportion of dividing CD4+ T cells was 0.5%; data not 
shown). 
Similarly, splenocytes exhibited no proliferation response in the absence 
of antigens as the mean frequency of dividing CD4+ T cells present was 0.0% 
(data not shown). 
Data from splenocyte proliferation assay apparently demonstrated that 
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Fig.3.6 Frequency of dividing CD4+ T cell present in various groups 
of mice. CFSE labelled splenocytes collected from sensitized mice (‘Trop’ 
group) or control groups (‘PBS’ group or ‘His’ group) were cultured with 
either recombinant shrimp tropomyosin (rMet e 1), phytohemagglutinin 
(PHA), bovine serum albumin (BSA) or in the absence of antigen (medium 
alone) for eight days. They were harvested, stained with anti-CD 4-PE and 
analyzed by FACS. Representative intensity histograms of CFSE show the 
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Figure 3.7 Shrimp tropomyosin-specific proliferation response of CD4+ 
T cells in the three groups of mice (see Fig. 3.3 for the abbreviations of 
groups). Each point represents the percentage of dividing CD4+ cells 
determined in individual mouse and the horizontal line is the median. 
Number of mice in each group is shown in parentheses. Different letters, a or 
b, at the top of the data points indicate there is a significant difference 
between 'Trop' and control (‘PBS’ and ‘His，）groups (p<0.05). 
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3.3.6 Cytokine profiles of restimulated splenocytes 
To characterize the polarization pattern of the T cell response, cytokines 
produced by splenocytes from the three groups of mice were detected by 
cytokine antibody array. Visual interpretation (Fig. 3.8) and densitometric 
analysis (Fig. 3.9) of array images suggested that expression of interleukin-3 
(IL-3), interleukin-4 (IL-4), interJeukin-5 (IL-5), interleukin-6 (IL-6), 
interleukin-13 (IL-13), interleukin-17 (IL-17), interferon-gamma (IFN-y) and 
monocyte chemotactic protein-1 (MCP-1) was higher in culture supernatant 
of splenocytes from sensitized mice than that of PBS-fed mice. Among them, 
IL-5 and IL-13 were only expressed in the splenocyte cultures from 
sensitized mice. Interestingly, expression levels of IL-6 and IFN-y were 
similar between sensitized mice and His-fed control group. 
To further quantify the levels of IL-4 and IFN-y in the splenocyte 
culture supernatant, their levels were determined by ELISA. Statistical 
analysis showed that level of IL-4 was higher in sensitized mice than that of 
the two control groups (Fig. 3.10), while there are no differences between the 
two control groups. 
As demonstrated by the cytokine array analysis, ELISA also indicated 
IFN-y level was statistically higher in splenocyte cultures of sensitized mice 
when compared with those in the PBS-fed group (Fig. 3.11). It also 
demonstrated that level of IFN-y was similar between sensitized and His 
tag-fed group. Altogether, results of ELISA were consistent with that from 
the cytokine array analysis. Calculation of the ratio of IL-4 to IFN-y and the 
comparison (Fig. 3.12) showed that the ratio was significantly higher in the 
sensitized mice than in the two control groups (p<0.05; Kruskal-Wallis test 
after arc sine transformation). 
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A B C D E F G H 
1 Positive Positive Negative Negative GCSF GM-CSF IL-2 IL-3 
2 Positive Positive Negative Negative GCSF GM-CSF IL-2 IL-3 
3 IL-4 IL-5 IL-6 IL-9 IL-10 IL-12 IL-12p70 IL-13 
4 IL-4 IL-5 IL-6 IL-9 IL-10 IL-12 IL-12p70 IL-13 
5 IL-17 IFN-Y MCP-1 MCP-5 RANTES SCF STNFRI TNF-a 
6 IL-17 IFN-Y MCP-1 MCP-5 RANTES SCF sTNFRI TNF-a 
7 TPO VEGF Blank Blank Blank Blank Blank Positive 
8 TPO VEGF Blank Blank Blank Blank Blank Positive 
Figure 3.8 Images of mouse cytokine antibody array. 23 kinds of 
cytokines were dotted in duplicate onto the membrane. Top: Representative 
antibody arrays incubated with pooled culture supematants from various 
groups of mice (see Fig. 3.3 for abbreviations of the groups). Four dots in the 
upper left and two dots in the lower right comers of the membrane indicate 
the positive controls for determining the orientation of the image. Bottom: A 
table showing the position of cytokines dotted on the membrane. 
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Figure 3.9 Detection of mean intensities of cytokines in the three groups 
(see legend of Fig. 3.3 for abbreviations of the groups of mice). The bar chart 
represents the average mean intensities of cytokine dots from two 
independent experiments. 
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Figure 3.10 Level of IL-4 produced from splenocytes in response to the 
stimulation of recombinant shrimp tropomyosin in various groups of mice 
(see legend of Fig. 3.3 for abbreviations of the groups). Each point represents 
the level of cytokines produced from individual splenocyte culture. Different 
letters, a or b, indicate there is a significant difference between ‘Trop’ and the 
two control groups (p<0.05). 
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Figure 3.11 Level of IFN-y produced from splenocytes in response to the 
stimulation of recombinant shrimp tropomyosin in various groups of mice 
(see legend of Fig. 3.3 for abbreviations of the groups). Each point represents 
the level of cytokines produced from individual splenocyte culture. Different 
letters, a or b, indicate there is a significant difference between ‘Trop’ group 
and ‘PBS’ group, but no difference between ‘Trop’ and ‘His，group (p<0.05). 
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Figure 3.12 Ratio of IL-4 to IFN-y levels produced from splenocytes in 
response to the stimulation of recombinant shrimp tropomyosin in various 
groups of mice (see legend of Fig. 3.3 for abbreviations of the groups). Each 
point represents the ratio of levels produced from individual splenocyte 
culture. Different letters, a or b, indicate there is a significant difference 
between ‘Trop’ and the two control groups (p<0.05). 
3.3.7 Histology of small intestine 
No significant histological changes were observed between sensitized 
and control mice (Fig. 3.13). Similar length of villi was found in all groups 
of mice. In addition, there was a regular arrangement of single-layered 
cuboidal enterocytes in all groups. However, it was observed that some 
intestinal specimens from sensitized mice showed fusion of some villi. Since 
it was only observed some but not all of the sections, it was not defined as a 
positive allergic response. On the other hand, no edema was observed in the 
lamina propria region. Lastly, no infiltration of lymphocytes or eosinophils 
was found in lamina propria or epithelial layers. It was noted that plasma 




Figure 3.13 Histology of small intestine of mice after challenge. No 
positive allergic responses were observed in jejunum region of small 
intestine of sensitized mice and sacrificed 24 hours after challenge (Panel A; 
20X magnification), six days after challenge (Panel B; 40X magnification), 
and PBS-fed control mice (Panel C; 40X magnification). 
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3.4 Discussion 
In this study, hypersensitive reactions, including behavioural and 
morphological changes, and humoral response, were evaluated and the 
findings are similar to those in the previous study (Tang, 2004). In both 
studies, systemic anaphylaxis responses were provoked in sensitized mice 
after the oral challenge of recombinant shrimp tropomyosin with cholera 
toxin. In some of these mice, laboured respiration and cutaneous reactions, 
represented by the swelling of eyes and noses, were observed. These 
responses mimic the clinical symptoms of angioedema and difficulty in 
breathing in food allergic patients immediately after the ingestion of food 
allergens (Nowak-Wegrzyn et al., 2006). Furthermore, scratching behaviour 
was observed in all sensitized mice after challenge. In fact, it represents one 
of the human seafood allergic responses after the ingestion of shellfish. 
Scratching behaviour was also observed in other mouse models of food 
allergies, in which mice were either fed with whole peanut extract (Hsieh et 
al., 2003) or buckwheat flour extract (Lee et al., 2005). 
Through years of researches, it is evident that IgE production is the 
initiator of a series of immediate hypersensitive responses in allergic patients. 
Therefore, detection of allergen-specific IgE in the patients' sera is now 
widely used for diagnosis of allergic diseases (Nowak-Wegrzyn et al., 2006). 
Similar to the previous study (Tang, 2004)，shrimp tropomyosin-specific IgE 
level were significantly increased only in sensitized mice, but not in the 
control. However, there was a difference on the IgE level in the two studies. 
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The mice in Tang's study (2004) showed a higher IgE level after challenge. 
In sum, the murine model could effectively mimic humoral response in 
allergic patients. 
To further assessing whether the allergic reactions in this model are 
IgE-mediated, passive cutaneous anaphylaxis (PCA) test was employed. 
Vascular leakage was indicated by the presence of blue dye around the sites 
where sera were injected. In this study, significant vascular leakage was only 
observed at the site where pooled sera from sensitized mice were injected. 
Similar observation was found in the previous study (Tang, 2004). This 
reaction would be abrogated by heat inactivation of immune sera. Such 
reactions were not observed at the other sites where sera from control mice 
were injected. These evidences implied that serological IgE level correlated 
with the induction of PCA reactions. When these IgE antibodies were 
passively transferred, they would associate with the mast cells in naive mice. 
Cross-linking of these antibodies by shrimp tropomyosin which was 
administrated intravenously into naive mice would release chemical 
mediators, such as histamine. These mediators would cause vasodilation at 
the injection site and thus result in the release of the blue dye from the blood 
vessel. This demonstrated IgE was the reagenic antibody in this model and 
only sensitized mice produced significantly high IgE antibody level in their 
blood. This result was evident in other animal models of food allergy (Helm 
et al., 2002; Li et al. 2000). For example, Li et al. (2000) also demonstrated 
that positive PCA reactions were only observed when sera from sensitized 
mice immunized with peanut allergens were injected. This test correlates the 
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relationship of IgE level and cutaneous reactions in animal models as well as 
in IgE-mediated allergic patients. 
Apart from humoral responses, T cell responses to shrimp tropomyosin 
were assessed using a splenocyte culture system and CFSE labelling method. 
Using this fluorescent dye for tracking food-antigen specific T cells was first 
introduced by Turcanu et al. (2003). This dye is a membrane-permanent dye 
that binds the amino groups of cytoplasmic proteins with its 
succinimidyl-reactive groups (Lyons et al., 2001; Weston et al” 1990). When 
cells divide, CFSE-labelled proteins are equally distributed between the 
daughter cells, thus halving the fluorescence intensity with each division. 
Consequently, dividing cells will lose their fluorescence and can be 
i 
distinguished from those non-dividing ones in culture. Applying this 
labelling method is more advantageous than using conventional radioactive 
isotope labelling technique as no radioactive material is handled and specific 
responses of each splenocytes can be traced. This provides a basis for 
cloning antigen-specific T clones in studying their roles in the induction of 
food allergy in human or in animal model. 
Although the role of allergen-specific T cells in the allergic responses 
has not been fully elucidated, it is widely accepted that CD4+ cell activation 
and Th2 cytokine production are involved in directing IgE antibody 
production in atopic patients. Activation of T cells is represented by the 
clonal expansion under in vitro stimulation. For example, in some clinical 
studies, in vitro culture with ovalbumin or peanut allergens promoted the 
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proliferation of allergen-specific CD4+ cells obtained from patients with 
cow's milk allergy (Tsuge et al., 2006) or peanut allergy (Turcanu et al., 
2003)，but not in non-allergic controls. In this study, proliferation level of 
shrimp tropomyosin-specific CD4+ T cells was significantly higher in 
sensitized mice than that of the two control groups. Furthermore, culture 
with an irrelevant antigen (i.e. BSA) only provoked a very weak proliferative 
response of CD4+ T cells in sensitized mice. These findings indicated that 
oral sensitization of shrimp tropomyosin induces shrimp 
tropomyosin-specific CD4+ cells in sensitized mice and in vitro culture with 
shrimp tropomyosin provokes specific clonal expansion of these T cells. This 
demonstrates our model was successful in mimicking T cell responses of 
allergic patients. In the long run, cloning of shrimp tropomyosin-specific 
CD4+ T cells can aid in studies on the interaction of T cells with shrimp 
tropomyosin for identifying T cell epitopes. 
In addition to the proliferation response, expression profile of cytokine 
was also analyzed. Cytokines play an important role in polarizing the 
differentiation of helper T cells and determining the isotype of antibody 
produced during various immune responses (see Chapter 2). It is also 
important in maintaining normal cell function and thus changing the balance 
between different families of cytokines can result in various forms of 
diseases (Huang et al., 2003). Although detailed mechanisms of food allergy 
is still unclear, it is believed that Th2 associated cytokines play an important 
role in the induction process (Mansueto et al., 2006). Understanding the 
cytokine expression profile in sensitized mice may reveal the underlying 
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mechanism during different phases of shrimp allergy. To achieve this goal, 
cytokine antibody array and ELISA were employed. Cytokine antibody array 
can provide sensitive and simultaneous detection of multiple cytokines 
(Huang et al., 2003). This will allow a more comprehensive analysis on 
cytokine production in sensitized mice, and may thus help identifying 
potential therapeutic molecular target (Huang et al., 2003). On the other hand, 
traditional ELISA was used for quantifying the levels of IFN-y and IL-4. The 
two cytokines are the typical representatives produced from two lineages of 
helper T cells, Thl and Th2 cell respectively. Quantitative analysis of ELISA 
can further validate the qualitative findings from cytokine antibody array. 
In this study, cytokine array demonstrates that several cytokines were 
expressed at higher levels in sensitized mice than in the PBS-fed control 
group. It included Thl cytokine IFN-y, Th2 cytokines IL-3, IL-4, IL-5, IL-6 
and IL-13, and inflammatory associated cytokine IL-17. The elevated levels 
of IL-4 and IFN-y in sensitized mice were also confirmed by ELISA. 
Various clinical investigations have demonstrated that a shift in 
Thl/Th2 balance in favour of Th2 plays a central role in mediating food 
allergy (Andre et al, 1996; Maggi et al” 1998). In the present study, 
increased levels of various Th2 associated cytokines in splenocyte culture 
from sensitized mice were observed. Ratio of IL-4/IFN-Y also demonstrates 
that Th2 response predominates in sensitized mice. These cytokines are well 
studied for their roles in the induction and maintenance of the allergic 
responses. IL-4 was identified as a growth and differentiation factor for 
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lymphocytes, mast cells and eosinophils (Ricci et al., 1997). The presence of 
these proinflammatory cells would result in gastrointestinal inflammation in 
patients. Acting with IL-13, they promote B cell activation and isotype 
switching of antibody towards IgE synthesis (Ryzhov et al., 2004). IL-5 
mediates eosinophils differentiation and proliferation in bone marrow and 
acts as a chemotactic factor in recruiting eosinophils from bone marrow to 
target tissues (Gelfand, 2004). Although it is suggested that eosinophils can 
be recruited in the absence of IL-5 (Hogan et al., 2000), unique expression 
pattern of IL-5 in this model highlights the important role of this cytokine in 
shrimp allergy. In general, the expression pattern of Th2 cytokines in this 
mouse model is similar to that in food allergic patients. On the other hand, 
accumulating evidences, based on studies of asthma and other food allergic 
models, have suggested that the Th2 hypothesis is too simplistic (van Wijk et 
al, 2004). Instead, it has been proposed that allergic responses may be the 
result of antigen-specific mixed Thl- and Th2-type cytokine responses. 
Numerous reports demonstrated that elevated level of IFN-y, a typical 
indicator of Thl response, was observed in allergic patients and 
peanut-sensitized,mice (Holen et al., 2001; Ng et al., 2002; Smart et al., 2002; 
van Wijk et al, 2004). This phenomenon was also observed in this mouse 
model. Re-stimulated splenocytes from shrimp tropomyosin sensitized mice 
produced more IFN-y than that from PBS-fed mice. It has been proposed that 
elevated level of IFN-y in the gut may induce upregulation of major 
histocompatibility complex class II (MHC II) on epithelial cells in the small 
intestine (Zhang et al., 1990) and increase permeability of epithelial layer in 
the gut (Adams et al, 1993), thus increasing efficacy in antigen uptake in the 
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sensitization phase of allergic reactions. 
Despite the hypothesis of mixed Thl/Th2 response, a more complicated 
cytokine network in the induction of allergic disorders was also proposed. 
IL-17 cytokine family is a newly discovered group of cytokines. In vitro 
studies have indicated a proinflammatory role of IL-17 as it is linked to 
tissue neutrophil recruitment in mice (Kolls & Leden，2004). Nakae et al. 
(2002) also suggested that level of IL-17 is closely correlated with the 
production of IgE and Th2 cytokines. Their investigation demonstrates that 
levels of IgE, IL-4 and IL-5 were reduced in IL-17-deficient mice, which 
showed a reduced level of airway hypersensitive response. Thus, it appears 
IL-17 may have a systemic effect on the development of Th2 responses. Of 
interest, elevations of IL-17, IL-4, IL-5 and IgE were also observed in this 
study. However, as no similar models of food allergy have been developed, 
the role of IL-17 in the induction of food allergy remains to be elucidated. 
Despite the role of cytokines, chemokines also play a pivotal role in the 
pathogenesis of allergic disorders, especially as a mediator of allergic 
inflammation (Nickel et al” 1999). MCP-1 is one of the examples. 
Functional study showed that MCP-1 is involved in the migration of 
monocyte and natural killer cells to the inflamed tissues, activation of 
basophils and promotion of Th2 response (Nickel et al., 1999). Additionally, 
it was found to be significantly increased in asthmatic patients (Alam et al., 
1996) and ovalbumin-induced asthmatic mice (Gonzalo et al., 1998) as 
compared to non-asthmatic subjects. In the present study, elevation of 
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MCP-1 in sensitized mice suggested that this chemokine may also be 
involved in pathogenesis of food allergy. Altogether, the findings 
demonstrate the complexity of cytokine interaction in the development of 
food allergy. Further work are needed to determine the role and the 
interaction of these cytokines in eliciting the shrimp allergic responses in 
mice. This may provide the basis in identifying specific targets for the 
development of therapeutic strategies. 
Humoral and T cell responses of sensitized mice resemble those in 
allergic patients well. However, it is observed that intestinal anaphylaxis 
responses could not be mimicked clearly by this murine model. This 
illustrates the limitation of this murine model. In the previous study (Tang, 
2004), no significant infiltration of lymphocytes or other morphological 
changes were observed in the intestinal tissues from sensitized mice. Similar 
phenomenon was also observed in the present study. However, the presence 
of abundant plasma cells which are the differentiated B cells actively 
involved in antibody production in sensitized mice may explain the finding 
of a significant elevation of IgE level in those mice after sensitization and 
challenge. In contrast to the previous and present studies, intestinal 
anaphylaxis responses, including edema of lamina propria and sloughing of 
enterocytes at the tips of the villi in some parts of the sections, were clearly 
observed in the murine model of cow's milk allergy (Li et al., 1999). In their 
study, degranulation of mast cells was also clearly demonstrated. It is 
suspected that different time point at the tissue collection may contribute to 
the discrepancy of results between different studies. Future investigation may 
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be needed by shortening the collection time to a few hours after challenge, 
rather than six days after challenge. 
One important discussion point concerns the effect of replacing natural 
food extract with recombinant allergen for sensitization of mice. Recently, 
various animal models have been developed by utilizing recombinant 
allergens (Hirahara et al., 1998; Winkler et al., 2002; Reese et al., 2005). For 
instance, Winkler et al. (2002) used recombinant birch pollen allergen for 
studying airway hypersensitive responses in BALB/c mice. It has been 
recognized that the content and composition of recombinant allergen during 
the preparation can be easily controlled (Herz et al., 2004). This is rather 
difficult to achieve when the allergen is extracted from natural food sources. 
Consistent quality of testing allergens would increase the reproducibility of 
experimental conditions. Another advantage in using recombinant allergen is 
that it can allow specific analysis on each allergen, even from the same food 
source (Herz et al., 2004). This can allow the study on allergenicity and 
epitope mapping of each allergen, so that allergen-specific therapeutic 
strategies can be developed. These highlight the advantages of utilizing 
recombinant allergen in the study of allergic disorders. On the other hand, 
cautious evaluation is needed to understand whether any changes in 
conformation or constitution of recombinant allergens would alter the 
immune responses in animal models which aim at resembling those in 
human subjects. This is especially important in the study of the epitope 
identification. One of the considerations in this study is on the possible effect 
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presence of histidine tag may alter the conformation of the fusion protein, 
I 
thus leading to a difference in the immunogenicity between the recombinant 
shrimp tropomyosin and the native protein extracted from shrimp. As stated 
in Chapter 2, short peptides (less than eight amino acids) are 
immunologically ignored (York et al., 1999). Theoretically, histidine tag 
which consists of only six amino acid residues does not contribute to 
immunogenicity in mice. However, expression levels of IL-6 and IFN-y were 
found to be similar between tropomyosin-sensitized and His-tag-fed control 
mice. It may be due to the bystander cell response as these two cytokines can 
be originated from other cellular sources rather than tropomyosin-specific 
Th2 cells. Further study using flow cytometric analysis may be done to 
analyze the antigen-specificity in the production of these cytokines. 
Chapter 4 
General conclusion 
In this study, the hypersensitive responses to shrimp tropomyosin in an 
established murine model were further characterized. BALB/c mice were 
sensitized and challenged with recombinant shrimp tropomyosin (rMet e 1) 
and cholera toxin. The findings in the present study are listed as follows: 
1. Sensitized mice exhibited systemic hypersensitive responses, including 
swelling and scratching around nose and tail, pufflness around eyes and 
mouth, and laboured respiration. 
2. Elevation of shrimp-tropomyosin specific IgE level was first observed 
in sensitized mice after three times of sensitization. Significant level 
was observed after challenge. 
3. Positive result of passive cutaneous anaphylaxis test indicates that the 
reactions in sensitized mice are IgE-mediated. 
4. Under in vitro stimulation of shrimp tropomyosin, there is an activation 
of tropomyosin-specific CD4+ T cells from sensitized mice as indicated 
by the specific clonal expansion. 
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5. A mixed cytokine expression profile was recorded. Stimulated 
splenocytes secreted Thl (IFN-y), Th2 (IL-3, IL-4, IL-5, IL-6 and 
IL-13), proinflammatory cytokine (IL-17) and chemotactic factor 
(MCP-1). It is suggested that elevation in the levels of these cytokines 
and chemokines may result in the clinical symptoms observed in 
allergic patients. 
To conclude, the induced humoral and cellular responses in this murine 
model resemble those observed in allergic individuals. The following table 
summarizes the immune responses observed in this model and in atopic 
patients. 
Immune in this murine model In allergic patients 
responses 
Systemic 1. Scratching 1. Scratching 
hypersensitivity 2. Swelling of eyes and 2. Angioedema 
responses snouts 
3. Laboured respiration 3. Difficulty breathing 
Humoral Significant elevation of High level of allergen 
response shrimp tropomyosin specific specific IgE in patients' 
IgE in subsequent sera 
sensitizations 
T cell responses 1. Significant proliferation 1. Clonal expansion of 
under in vitro response of tropomyosin allergen-specific CD4+ 
stimulation of specific CD4+ T cells T cells, 
allergens 2. Increased expression 2. Expressions of Thl-
levels of Th 1 -’ and Th2-related 
Th2-related cytokines, cytokines were 
IL-17 and MCP-1 from increased. However, 
restimulated splenocytes elevations of IL-17 and 
MCP-1 were only 
reported in the studies 
on asthmatic patients. 
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Establishment of a murine model of shrimp allergy allows further 
studies on pathogenesis of the disorder and development of therapeutic 
strategies for the patients. As presented in previous chapters, our 
understanding on mechanisms of allergic diseases remains obscure. With this 
murine model, it is possible to characterize interactions in the immune 
system that contribute to the breakdown of oral tolerance during sensitization 
and effector phases of allergic reactions. In addition, this murine model may 
also serve as a tool in identifying T-cell and B-cell epitopes in shrimp 
tropomyosin which is the major cross-reactive shellfish allergen. Identifying 
allergenic regions in shrimp tropomyosin or specific cell types involved in 
the oral sensitization may help in developing new treatments for curing the 
shrimp allergic patients. To a further extent, the therapy may not only help 
shrimp allergic individuals, but also tropomyosin-related allergic patients. 
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